Cat. No. |
Product Name |
Information |
PC-42579 |
A-443654
Akt inhibitor
|
Rizavasertib (A-443654) is a potent and selective Akt inhibitor with Ki of 0.16 nM for Akt1/2/3. |
PC-42032 |
BAY-1125976
Akt inhibitor
|
BAY-1125976 is a potent and highly selective, allosteric AKT1/2 inhibitor with IC50 of 5.2/18 nM at 10 uM ATP. |
PC-45903 |
Perifosine
Akt inhibitor
|
Perifosine (KRX-0401, D21266) is an oral bioavailable alkylphospholipid, acts as an Akt inhibitor and a PI3K inhibitor, induces p21(WAF1) expression in squamous carcinoma cells through a p53-independent pathway. |
PC-42697 |
PF-AKT400
Akt inhibitor
|
PF-AKT400 is a broadly selective, potent, ATP-competitive Akt kinase inhibitor with IC50 of 0.5 nM (biochemical assay), and 0.31 nM (cell function assay). |
PC-24887 |
ML-B01
Akt inhibitor
|
ML-B01 is an ipatasertib analog and selective Akt inhibitor with IC50 of 2.0 nM and 136 nM for Akt1 and PKA respectively. |
PC-23340 |
Triciribine
Akt inhibitor
|
Triciribine is a purine analog and DNA synthesis inhibitor, also inhibits Akt and HIV-1/2 with IC50 of 130 nM, and 0.02-0.46 μM, respectively, selectively inhibits the phosphorylation and activation of all three Akt isoforms. |